华森制药：公司产品完成境内生产药品备案

Core Viewpoint - Huason Pharmaceutical announced the completion of domestic production registration for its product, Apselaziglan Tablets, with the National Medical Products Administration [2] Group 1 - The company has recently checked the National Medical Products Administration website and confirmed the registration of Apselaziglan Tablets [2] - The registration includes an application for the product's instructions to be adapted for elderly users [2] - The registration information has been publicly announced on the National Medical Products Administration website [2]